These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8548360)
1. The influence of a peptide sequence from PF-4 (CT-112) on type II collagen-induced arthritis in mice. Wooley PH; Whalen JD; Dutcher JA; Counts DF Inflamm Res; 1995 Aug; 44 Suppl 2():S125-6. PubMed ID: 8548360 [No Abstract] [Full Text] [Related]
2. A peptide sequence from platelet factor 4 (CT-112) is effective in the treatment of type II collagen induced arthritis in mice. Wooley PH; Schaefer C; Whalen JD; Dutcher JA; Counts DF J Rheumatol; 1997 May; 24(5):890-8. PubMed ID: 9150077 [TBL] [Abstract][Full Text] [Related]
3. CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model. Zimmerman DH; Taylor P; Bendele A; Carambula R; Duzant Y; Lowe V; O'Neill SP; Talor E; Rosenthal KS Int Immunopharmacol; 2010 Apr; 10(4):412-21. PubMed ID: 20074669 [TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of a combination of cofpropamine, a caffeine derivative, and cyclophosphamide on the development of adjuvant arthritis of rats and collagen arthritis of mice. Kröger H; Klosa J; Grätz R; Dietrich A; Ehrlich W; Wild A Gen Pharmacol; 1996 Oct; 27(7):1215-8. PubMed ID: 8981070 [TBL] [Abstract][Full Text] [Related]
5. 11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. Zhang L; Dong Y; Zou F; Wu M; Fan C; Ding Y Int Immunopharmacol; 2013 Nov; 17(3):489-94. PubMed ID: 23938253 [TBL] [Abstract][Full Text] [Related]
6. Systemic administration of TIMP in the treatment of collagen-induced arthritis in mice. Carmichael DF; Stricklin GP; Stuart JM Agents Actions; 1989 Jun; 27(3-4):378-9. PubMed ID: 2801328 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory activity of an orally active peptide sequence from PF-4 on acute inflammation and DTH. Talmadge JE; Kelsey LS; Brown GS; Counts DF Inflamm Res; 1995 Aug; 44 Suppl 2():S199-200. PubMed ID: 8548397 [No Abstract] [Full Text] [Related]
8. Effect of actarit on type II collagen-induced arthritis in mice. Fujisawa H; Nishimura T; Motonaga A; Inoue Y; Inoue K; Suzuka H; Yoshifusa H; Kimura K; Muramatsu M Arzneimittelforschung; 1994 Jan; 44(1):64-8. PubMed ID: 8135880 [TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. Kato G; Shimizu Y; Arai Y; Suzuki N; Sugamori Y; Maeda M; Takahashi M; Tamura Y; Wakabayashi N; Murali R; Ono T; Ohya K; Mise-Omata S; Aoki K Arthritis Res Ther; 2015 Sep; 17(1):251. PubMed ID: 26373710 [TBL] [Abstract][Full Text] [Related]
10. Effects of selective iNOS inhibition on type II collagen-induced arthritis in mice. Sakaguchi Y; Shirahase H; Ichikawa A; Kanda M; Nozaki Y; Uehara Y Life Sci; 2004 Sep; 75(19):2257-67. PubMed ID: 15350824 [TBL] [Abstract][Full Text] [Related]
12. Suppression of collagen-induced arthritis by lipopolysaccharide in DBA/1 mice. Zhao XX; Bi Y; Yin XY; Min R Eur Rev Med Pharmacol Sci; 2016; 20(3):441-6. PubMed ID: 26914117 [TBL] [Abstract][Full Text] [Related]
13. Gallium nitrate ameliorates type II collagen-induced arthritis in mice. Choi JH; Lee JH; Roh KH; Seo SK; Choi IW; Park SG; Lim JG; Lee WJ; Kim MH; Cho KR; Kim YJ Int Immunopharmacol; 2014 May; 20(1):269-75. PubMed ID: 24656780 [TBL] [Abstract][Full Text] [Related]
14. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages. Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877 [TBL] [Abstract][Full Text] [Related]
15. Studies on pharmacological activation of human immunoglobulin G by chemical modification and active subfragments. XIII. Effect of carboxamidemethylated Fc fragment (CM-Fc) on type II collagen-induced arthritis in DBA/1J mice. Mimura T; Itoh M; Gohgi H; Suzuki N; Takeuchi K; Tsujikawa K; Kohama Y Biol Pharm Bull; 1994 May; 17(5):623-6. PubMed ID: 7920420 [TBL] [Abstract][Full Text] [Related]
16. Torilin ameliorates type II collagen-induced arthritis in mouse model of rheumatoid arthritis. Endale M; Lee WM; Kwak YS; Kim NM; Kim BK; Kim SH; Cho J; Kim S; Park SC; Yun BS; Ko D; Rhee M Int Immunopharmacol; 2013 Jun; 16(2):232-42. PubMed ID: 23623942 [TBL] [Abstract][Full Text] [Related]
17. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma. Cuzzocrea S; Mazzon E; Dugo L; Patel NS; Serraino I; Di Paola R; Genovese T; Britti D; De Maio M; Caputi AP; Thiemermann C Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008 [TBL] [Abstract][Full Text] [Related]
18. Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist. Verdrengh M; Jonsson IM; Zaether O; Bajtner E; Holmdahl R; Tarkowski A Ann Rheum Dis; 2002 Sep; 61(9):829-31. PubMed ID: 12176810 [TBL] [Abstract][Full Text] [Related]
19. A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis. Myers LK; Rosloniec EF; Seyer JM; Stuart JM; Kang AH J Immunol; 1993 May; 150(10):4652-8. PubMed ID: 8482852 [TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis. Cuzzocrea S; Chatterjee PK; Mazzon E; McDonald MC; Dugo L; Di Paola R; Serraino I; Britti D; Caputi AP; Thiemermann C Eur J Pharmacol; 2002 Oct; 453(1):119-29. PubMed ID: 12393067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]